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Abstract
Background: The human cysteine rich protein 61 (CYR61, CCN1) as well as the other members of the CCN family of
genes play important roles in cellular processes such as proliferation, adhesion, migration and survival. These cellular
events are of special importance within the complex cellular interactions ongoing in bone remodeling. Previously, we
analyzed the role of CYR61/CCN1 as an extracellular signaling molecule in human osteoblasts. Since mesenchymal stem
cells of bone marrow are important progenitors for various differentiation pathways in bone and possess increasing
potential for regenerative medicine, here we aimed to analyze the expression of CCN family members in bone marrow-
derived human mesenchymal stem cells and along the osteogenic, the adipogenic and the chondrogenic differentiation.
Results:  Primary cultures of human mesenchymal stem cells were obtained from the femoral head of patients
undergoing total hip arthroplasty. Differentiation into adipocytes and osteoblasts was done in monolayer culture,
differentiation into chondrocytes was induced in high density cell pellet cultures. For either pathway, established
differentiation markers and CCN-members were analyzed at the mRNA level by RT-PCR and the CYR61/CCN1 protein
was analyzed by immunocytochemistry.
RT-PCR and histochemical analysis revealed the appropriate phenotype of differentiated cells (Alizarin-red S, Oil Red O,
Alcian blue, alkaline phosphatase; osteocalcin, collagen types I, II, IX, X, cbfa1, PPARγ , aggrecan). Mesenchymal stem cells
expressed CYR61/CCN1, CTGF/CCN2, CTGF-L/WISP2/CCN5 and WISP3/CCN6. The CYR61/CCN1 expression
decreased markedly during osteogenic differentiation, adipogenic differentiation and chondrogenic differentiation. These
results were confirmed by immuncytochemical analyses. WISP2/CCN5 RNA expression declined during adipogenic
differentiation and WISP3/CCN6 RNA expression was markedly reduced in chondrogenic differentiation.
Conclusion: The decrease in CYR61/CCN1 expression during the differentiation pathways of mesenchymal stem cells
into osteoblasts, adipocytes and chondrocytes suggests a specific role of CYR61/CCN1 for maintenance of the stem cell
phenotype. The differential expression of CTGF/CCN2, WISP2/CCN5, WISP3/CCN6 and mainly CYR61/CCN1
indicates, that these members of the CCN-family might be important regulators for bone marrow-derived mesenchymal
stem cells in the regulation of proliferation and initiation of specific differentiation pathways.
Published: 17 March 2005
Cell Communication and Signaling 2005, 3:5 doi:10.1186/1478-811X-3-5
Received: 03 February 2004
Accepted: 17 March 2005
This article is available from: http://www.biosignaling.com/content/3/1/5
© 2005 Schütze et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Cell Communication and Signaling 2005, 3:5 http://www.biosignaling.com/content/3/1/5
Page 2 of 12
(page number not for citation purposes)
Background
Members of the cysteine-rich61/connective tissue growth
factor/nephroblastoma overexpressed (CCN 1–3) family
of genes (CCN-family) function in processes such as pro-
liferation, differentiation as well as cell adhesion, migra-
tion and survival [1-3]. Additional members of this family
are Elm1/WISP1/CCN4, rCop1/WISP2/CTGF-L/CCN5
and WISP3/CCN6 [1,2,4]. The proteins mainly represent
matrix associated signal molecules and share a common
modular structure [5,6]. N-terminal amino acids have
been shown to be important for secretion of CYR61/
CCN1 [7]. Although CCN proteins share an insulin-like
growth factor binding protein (IGFBP)-like motif, no clear
experimental significance exists to suggest a function in
the IGF signaling pathway [8]. The von Willebrand type C
domain (VWC), the trombospondin type I domain and
the C-terminal module (which is absent in CTGF-L/
WISP2) are considered to be important for protein-pro-
tein interactions, either oligomerisation (VWC) or interac-
tions with extracellular matrix molecules and receptors.
Interaction partners of CCN proteins include integrin
receptors [9-15], surface heparan sulfate proteoglycans
(CYR61) [11], decorin and biglycan (WISP1) [16], and
fibulin 1C (NOVH) [17]. Additional binding partners are
likely to exist since interactions of CCN proteins in addi-
tional signal transduction pathways such as BMP and
TGF-β  signaling for CTGF/CCN2 [18] and CYR61/CCN1,
intracellular calcium signaling (NOV/CCN3) [19], the
notch pathway (NOV) [20] and the Wnt pathway
(CYR61/CCN1 have been described [21].
An important target for CCN proteins could be bone and
cartilage since the expression of CCN members in
chondrocytes and osteoblasts is known from animal mod-
els and human tissues, and the majority of the above men-
tioned receptors and pathways are also relevant to skeletal
homeostasis. CYR61/CCN1 is involved in chondrogenesis
in mice [22], is expressed in human bone at sites of bone
remodeling, in hypertrophic chondrocytes at the growth
plate [23], and in the fracture callus in rats [24]. In human
osteoblasts CYR61/CCN1 expression is regulated by a
variety of bone-relevant growth factors [25]. CTGF/CCN2
is also expressed in bone and cartilage [8,26]. The role in
skeleletal homeostasis and cartilage development is
strengthened by a mouse model with functional inactiva-
tion [27]. CCN5 has been implicated in osteoblast and
chondrocyte function [28]. CCN3 also is expressed in
chondrocytes and could play a role in chondrocyte differ-
entiation [3,6]. Mutations in the CCN6 gene are known to
be associated with pseudorheumatoid dysplasia [29].
Therefore, CCN proteins are relevant for skeletal growth
and development, e. g. bone and cartilage formation and
function and some of the CCN proteins could as well be
important in fracture repair and bone remodeling.
Bone marrow-derived mesenchymal stem cells (MSC) are
versatile cells which can differentiate into various cell
types including osteoblasts, chondrocytes and adipocytes.
MSC express markers of additional cell types, depending
on the environment or cell culture conditions [30-36].
Therefore, this in vitro differentiation system of osteo-
genic, adipogenic and chondrogenic differentiation
allows to investigate for genes which are temporally
expressed during differentiation pathways. Here we inves-
tigated the expression patterns of CCN family members
during these differentiation pathways using human bone
marrow-derived MSC. The results indicate that the expres-
sion of CCN-family members is dependent on the differ-
entiation status of human MSC in vitro.
Results
Lineage-specific differentiation of bone marrow-derived 
MSC
MSC obtained from 4 different patients each were used
throughout the individual differentiation pathways for
this study. As was described previously [36] monolayer
cultures treated with osteogenic supplements showed a
high percentage of alkaline-positive cells, stained positive
for mineralized matrix deposition and expressed the oste-
ogenic specific marker genes alkaline phosphatase and
osteocalcin (Fig. 1). Monolayer cell cultures treated with
adipogenic supplements showed cytoplasmic lipid drop-
lets and expressed LPL and PPARγ 2, characteristic for adi-
pocytes (Fig. 2). High density pellet cell cultures were
composed of morpholocically distinct, chondrocyte-like
cells, surrounded by a sulfated proteoglycan-rich extracel-
lular matrix and expressed collagen type II (Fig. 3).
Expression of CCN family members in undifferentiated 
MSC
Bone marrow-derived MSC prior to the initiation of the
various differentiation pathways expressed CYR61/CCN1,
CTGF/CCN2, CCN5 and CCN6 genes by RT-PCR analysis
at high levels (Fig 4, 6 and 7, left lane each). No signals
were obtained for CCN3 and for CCN4 expression in
undifferentiated MSC as well as during differentiation
pathways derived thereof, even after variations of the RT-
PCR procedure. Further analyses, therefore, focused on
CYR61/CCN1, CTGF/CCN2, WISP2/CCN5 and WISP3/
CCN6 (see below).
Differential expression of CYR61/CCN1 during osteogenic 
differentiation
A marked decrease in the expression of CYR61/CCN1 was
observed during osteogenic differentiation. At the mRNA
level RT-PCR analysis revealed a 6.9 ± 2.2-fold decrease (n
= 4) in CYR61/CCN1 levels after 4 weeks of osteogenic
differentiation, compared to undifferentiated MSC (Fig.
4). RT-PCR analysis for other CCN-members in this study
did not display changes in PCR product intensity duringCell Communication and Signaling 2005, 3:5 http://www.biosignaling.com/content/3/1/5
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osteogenic differentiation. At the protein level, immuno-
cytochemistry showed a decrease in CYR61/CCN1 signal
from differentiated cells compared to undifferentiated
MSC (Fig. 5).
Differential expression of CYR61/CCN1, CTGF/CCN2 and 
WISP2/CCN5 during adipogenic differentiation
RT-PCR analysis of the CCN family members during adi-
pogenic differentiation is shown in Fig 6. CYR61/CCN1
Marker analysis of osteoblasts derived from MSC Figure 1
Marker analysis of osteoblasts derived from MSC. Human bone marrow-derived MSC were differentiated into osteob-
lasts according to the methods section. were compared A) RT-PCR results for alkaline phosphatase and osteocalcin, B) Ali-
zarin Red staining of calcium phosphate deposits in differentiated osteoblasts, C and D) Alkaline phosphatase staining of MSC 
and osteoblasts after 4 weeks of differentiation, respectively, (scale bar = 100 µm).
Marker analysis of adipocytes derived from MSC Figure 2
Marker analysis of adipocytes derived from MSC. Human bone marrow-derived MSC were differentiated into adi-
pocytes according to the methods section. A) RT-PCR results for lipoprotein lipase (LPL) and peroxisome proliferators-acti-
vated receptor γ 2 (PPARγ 2), B) staining for lipid droplets (Oil-Red O), (scale bar = 100 µm).
undifferentiated 3 weeks
osteocalcin
alkaline phosphatase
actin
A) B)
C) D)
undifferentiated 2 weeks
lipoprotein lipase
PPARγ2
actin
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and WISP2/CCN5 were expressed prior to the initiation of
adipogenesis and in initial stages of the differentiation
pathway. However, in differentiated adipocytes after 2
weeks of differentiation almost undetectable levels were
observed (n = 4). Due to the low expression levels densit-
ometry was not possible. RT-PCR for CTGF/CCN2
revealed a slight reduction of the PCR product levels
towards differentiated adipocytes (2.1 ± 0.8-fold). WISP3/
CCN6 PCR product intensity did not change during adi-
pogenic differentiation.
Differential expression of CYR61/CCN1 and WISP3/CCN6 
during chondrogenic differentiation
In high-density cell pellets prior to the initiation of chon-
drogenic differentiation RT-PCR analysis for CYR61/
CCN1 and WISP3/CCN6 revealed high levels of RNA
expression. During differentiation after one week signals
for CYR61/CCN1dropped to undetectable levels. (Fig. 7).
Therefore, densitometry for CYR61/CCN1 RT-PCR prod-
ucts after differentiation was not possible. PCR product
intensity for WISP3/CCN6 was reduced 5.5 ± 0.6-fold (n
= 4). RT-PCR for CTGF/CCN2 revealed a slight reduction
during chondrogenic differentiation of 1.9 ± 0.6-fold.
WISP2/CCN5 PCR products did not reveal differences in
intensity along the chondrogenic differentiation of MSC.
Immunohistochemistry of slides cut through the center of
the pellets indicated high levels of CYR61/CCN1 protein
prior to the initiation of differentiation. After three weeks
of chondrogenic differentiation a reduced signal intensity
at the periphery of the pellet was observed (Fig. 8).
Marker analysis of chondrocytes derived from MSC Figure 3
Marker analysis of chondrocytes derived from MSC. Human bone marrow-derived MSC were differentiated into 
chondrocytes according to the methods section. A) RT-PCR analyses for chondrogenic markes as is indicated, B) H & E-stain-
ing, C) Alcian blue staining (H & E-counterstaining, D) example of negative control for immunohistochemical analyses (DAPI-
counterstained), E) immunohiostochemical staining for collagen type II, F) immunohiostochemical staining for chondroitin sul-
phate 4, G) immunohiostochemical staining for chondroitin sulphate 6, (scale bar = 100 µm).Cell Communication and Signaling 2005, 3:5 http://www.biosignaling.com/content/3/1/5
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Discussion
CCN proteins play important roles in growth and differ-
entiation and are involved in cellular processes such as
migration, adhesion and survival [1,2,6]. A major role for
CYR61/CCN1 and CTGF/CCN2 in bone and cartilage
development is indicated by animal studies
[6,22,27,37,38]. In the adult both CCN-family members
have been associated with remodeling and repair in tis-
sues such as bone and cartilage, muscle, the vascular sys-
tem and the nervous system as reviewed in [2,3,39,40].
The culture of human bone marrow-derived MSC applied
in this study allows the analysis of CCN protein expres-
sion and function during differentiation pathways. Partic-
ularly, we investigated the expression of CCN family
members during the differentiation of human bone
marrow-derived MSC into osteoblasts, adipocytes and
chondrocytes. Results showed that CYR61/CCN1 in all
pathways, and CTGF/CCN2, WISP2/CTGF-L/CCN5 and
WISP3/CCN6 in specific pathways were differentially
expressed and therefore could participate in MSC function
and lineage progression.
Quantitative measurements of mRNA levels have not
been performed in this study. This limits the possibility to
detect subtle differences in CCN mRNA expression. How-
ever, the reproducibly observed differences for CYR61/
CCN1, WISP2/CCN5 and WISP3/CCN6 expression along
differentiation pathways were sufficiently intense to be
detected by the conventional RT-PCR procedure applied.
Except for NOV/CCN3 and WISP1/CCN4, all CCN family
members investigated were expressed in undifferentiated
MSC and/or along differentiation pathways derived
thereof. Expression of lineage-specific cell markers at the
RT-PCR level as well as histochemical analysis for
RT-PCR analysis of CCN family members during osteogenic  differentiation Figure 4
RT-PCR analysis of CCN family members during 
osteogenic differentiation. Human bone marrow-derived 
MSC were differentiated into osteoblasts according to the 
methods section. Total RNA was isolated and reverse tran-
scribed from undifferentiated cells and differentiated cells 
after 4 weeks. PCR products for CCN family members as 
indicated were subjected to agarose gel electrophoresis.
undifferentiated 4 weeks
CYR61/CCN1
CTGF/CCN2
WISP2/CCN5
WISP3/CCN6
actin
RT-PCR analysis of CCN family members during adipogenic  differentiation Figure 6
RT-PCR analysis of CCN family members during adi-
pogenic differentiation. Human bone marrow-derived 
MSC were differentiated into adipocytes according to the 
methods section. Total RNA was isolated and reverse tran-
scribed from undifferentiated cells and differentiated cells 
after 1 and 2 weeks. PCRproducts for CCN family members 
as indicated were subjected to agarose gel electrophoresis.
undifferentiated 1 week 2 weeks
CYR61/CCN1
CTGF/CCN2
WISP2/CCN5
WISP3/CCN6
actinCell Communication and Signaling 2005, 3:5 http://www.biosignaling.com/content/3/1/5
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mineralized matrix deposition, lipid droplets and carti-
lage-specific extracellular matrix revealed that the appro-
priate conditions for differentiation of MSC were applied.
Whereas NOV/CCN3 expression has been described in
the murine growth plate and murine chondrosarcomas
[41], our failure to detect NOC/CCN3 along chondro-
genic differentiation could rely on species and/or cell spe-
cific differences, however, we cannot exclude low
expression levels below the detection limit of the conven-
tional RT-PCR procedure.
We never observed an increase of PCR product intensity in
RT-PCR of any CCN family member during lineage-spe-
cific differentiation. Therefore, corresponding steady state
mRNA levels of CCN members were highest in undiffer-
entiated MSC compared to differentiated cell types. This
might indicate specific functions of CCN proteins in the
precursor cells prior to the onset of differentiation path-
ways. These functions could be associated with the known
positive growth regulation capabilities of CYR61/CCN1,
CTGF/CCN2 and WISP2/CCN5.
Particularly, CYR61/CCN1 could play a significant func-
tion in MSC in vitro since its expression was largely
decreased during all differentiation pathways under study.
The decreased PCR product intensity in RT-PCR analysis
during differentiation, however, does not prove the
absence of particular functions in differentiated cells. The
protein can be stably bound within the extracellular
matrix. The results of immunohistochemistry for CYR61/
CCN1 expression after osteogenic differentiation indi-
cated lower but still detectable signals and in high-density
cell pellet cultures used for chondrogenic differentiation a
reduced but significant protein expression was observed.
Despite lower expression of CYR61/CCN1 in
differentiated cells, the mRNA and protein levels can be
upregulated by various bone relevant growth factors [25].
Our finding of undetectable CYR61/CCN1 expression in
MSC-derived chondroctes is in contrast to reports describ-
ing the CYR61-dependent regulation of chondrogenesis
in mouse limb bud mesenchymal stem cells [22] and its
expression in chondrocytes during fracture repair in rats
[24]. This difference could result from species and/or cell
specific differences or depend on the detection limit as is
discussed above.
CTGF/CCN2 was constitutively expressed at the RT-PCR
level during osteogenic differentiation and only slightly
reduced during adipogenic and chondrogenic differentia-
tion. CTGF/CCN2 is able to stimulate the expression of
markers of differentiated osteoblasts and chondrocytes in
vitro  [8,26,42]. WISP2/CCN5 expression was only
decreased during adipogenic differentiation in a pattern
that paralleled CYR61/CCN1 expression, but was consti-
tutively expressed in the other differentiation pathways.
WISP3/CCN6 expression was downregulated during
chondrogenic differentiation. Since mutations in the
WISP3/CCN6 gene result in pseudorheumatoid dysplasia
[29] an important role in cartilage formation and/or initi-
ation of chondrogenesis is possible.
With regard to the molecular signalling mechanisms, the
CCN family members act in a variety of signalling
pathways such as notch, BMP, Wnt and intracellular cal-
cium signalling [18-21] as is reviewed in [2,3]. Several of
these identified pathways are relevant for differentiation
lineages and cell fate decisions. Particularly the notch,
BMP and Wnt signaling pathways are relevant for the
developing skeleton. The adhesive signalling capabilities,
mainly studied for CYR61/CCN1 are of special relevance
for tissue homeostasis in the bone and cartilage microen-
vironment [11,13,43]. Mainly CYR61/CCN1 [22] and
CTGF [27,44-46] appear to regulate bone and cartilage
formation in embryonic development. Tissue repair in the
adult could comprehense cellular processes occurring in
the developmental stage. Thus, the growing importance of
MSC for targeted tissue repair could, in part, rely on CCN-
RT-PCR analysis of CCN family members during chondro- genic differentiation Figure 7
RT-PCR analysis of CCN family members during 
chondrogenic differentiation. Human bone marrow-
derived MSC were differentiated into chondrocytes for 3 
weeks in high-density cell pellets according to the methods 
section. Total RNA was isolated and reverse transcribed 
from undifferentiated cells and differentiated cells after 1, 2 
and 3 weeks. PCR products for CCN family members as indi-
cated were subjected to agarose gel electrophoresis.
undifferentiated 1 week 2 weeks 3 weeks
CYR61/CCN1
CTGF/CCN2
WISP2/CCN5
WISP3/CCN6
actinCell Communication and Signaling 2005, 3:5 http://www.biosignaling.com/content/3/1/5
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Expression of the CYR61 protein during osteogenic differentiation Figure 5
Expression of the CYR61 protein during osteogenic differentiation. Human bone marrow-derived MSC were differ-
entiated into cells of the osteogenic lineage. Undifferentiated cells and differentiated cells after 4 weeks were fixed and sub-
jected to immunohistochemistry as outlined in the methods section (scale bar = 100 µm).
Expression of CYR61 protein in high-density pellets during chondrogenic differentiation Figure 8
Expression of CYR61 protein in high-density pellets during chondrogenic differentiation. Human bone marrow-
derived MSC were differentiated into chondrocytes in high-density cell pellets. Slides from pellets of the undifferentiated cells 
and differentiated cells after 3 weeks were cut through the center of the pellet, fixed and subjected to immunohistochemistry 
as outlined in the methods section. (scale bar = 100 µm).
undifferentiated MSC 4 weeks osteogenic differentiation
undifferentiated MSC 3 weeks chondrogenic differentiationCell Communication and Signaling 2005, 3:5 http://www.biosignaling.com/content/3/1/5
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protein function. The differential expression of CCN fam-
ily members, particularly CYR61/CCN1 mainly in MSC
compared to differentiated cells could indicate a func-
tional importance of these proteins for tissue engineering
purposes.
Conclusion
The high expression of CCN family members in MSC and
the sharp decline in RNA expression levels during differ-
entiation of MSC into osteoblasts, adipocytes and
chondrocytes, particularly for CYR61/CCN1 but also for
CTGF/CCN2, WISP2/CCN5, WISP3/CCN6 in selected
pathways, could indicate that these members of the CCN-
family might be important regulators for bone marrow-
derived MSC. MSC possess a growing importance in tar-
geted tissue repair in the adult. Repair processes in the
adult could involve cellular events occuring during devel-
opment. Since the CCN family members (mainly CYR61/
CCN1 and CTGF/CCN2) play important roles in the
developing skeleton and in angiogenesis, these factors
likely could play a role in targeted tissue repair and could
improve tissue engineering strategies (Fig. 9).
Methods
Materials
FCS was supplied by Gibco (Eggenstein, Germany). Taq
Polymerase was purchased from Amersham Pharmacia
(Freiburg, Germany). An anti mouse CYR61 polyclonal
antiserum was obtained from Munin Corp. (Chicago,
USA). All other chemicals were of the highest purity
available.
Isolation of MSC
MSC were isolated from human bone marrow obtained
from the femoral head of patients undergoing total hip
arthroplasty using a modified protocol [36] originally
described by Haynesworth et al. [31]. Usage of patient
material was approved by the local ethics commitee of the
University of Würzburg and written consent was obtained
from each patient. MSC from 4 patients were used for this
study (3 male, 1 female), age between 51 and 62 years.
CCN proteins could improve tissue engineering strategies Figure 9
CCN proteins could improve tissue engineering strategies. Human bone marrow-derived MSC express and secrete 
CCN family proteins. Mainly CCN 1, 2, 5 and 6 are expressed in undifferentiated cells. Particularly CYR61/CCN1 and CTGF/
CCN2 are important regulators in the developing skeleton and represent angiogenic modulators. Targeted tissue repair in the 
adult could, in part, rely on this dual role of CCN proteins allowing for improvement of tissue engineering strategies.
MSC
endothelial cell
growth factors
(bFGF,TGFβ)
angiogenesis
CCN-proteins
secretion and
autoregulation
migration, adhesion, cell-
communication, tissue repair
improve tissue engineeringCell Communication and Signaling 2005, 3:5 http://www.biosignaling.com/content/3/1/5
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Trabecular bone plugs were harvested from the cutting
plane of the femoral head and transferred to 50 ml conical
tubes containing DMEM/F12 medium (PAA, Cölbe,
Germany). After vortexing and centrifugation (1000 rpm,
5 min) the pellet containing bone plugs and released cells
was reconstituted in DMEM/F12 medium supplemented
with 10% fetal bovine serum (FBS), antibiotics (50 I.U.
penicillin/ml and 50 µg streptomycin/ml) and 50 µg/ml
ascorbate (complete medium). After repeated washings,
the released cells were pelleted (1000 rpm, 5 min), sus-
pended in complete medium, plated at a density of 60 ×
106 cells per 150 cm2 tissue culture flask and maintained
at 37°C in 5% CO2. Non adherent cells were removed
after 2 days and subsequently the medium was changed
every 2 days until the cell cultures reached confluency.
Osteogenic differentiation of MSC
Cells were plated in 6-well plates or chamber slides in
complete medium. At confluency osteogenic differentia-
tion was initiated using the complete medium
supplemented with 10 mM β -glycerophosphate and 50
µg/ml ascorbate. Medium was changed every 2 days up to
4 weeks. To monitor osteogenic differentiation RT-PCR
analysis for alkaline phosphatase, osteopontin and osteo-
calcin was performed as well as stainings for alkaline
phosphatase (Sigma, Taufkirchen, Germany, Kit No. 86)
and calcium phosphate deposition (Alizarin Red S) were
performed as described by Nöth et al. [36].
Adipogenic differentiation of MSC
Cells were plated in 6-well plates or chamber slides in
DMEM with 10 % FBS. At confluency, adipogenic differ-
entiation was initiated using the same medium supple-
mented with 1 µM dexamethasone, 0.5 mM
isobutylmethylxanthine, 1 µg/ml insulin and 100 µM
indomethacin. Medium was changed every 2 days up to 2
weeks. To monitor adipogenic differentiation RT-PCR
analysis for lipoprotein lipase (LPL) and peroxisome pro-
liferator-activated receptor γ 2 (PPARγ 2) was performed,
and a staining for lipid droplets (Oil Red O) as described
[33,36].
Chondrogenic differentiation of MSC
Cells were cultured as high-density pellet cultures in a
serum-free medium as described previously [32,33]. 200,
000 cells were centrifuged for 5 min and 1000 rpm in 15
ml conical tubes and the pellets cultured for 3 weeks at
37°C in 5 % CO2. The chondrogenic medium consisted of
DMEM supplemented with 10 ng/ml transforming
growth factor β 1 (Stathmann, Hamburg, Germany), 100
nM dexamethasone, 50 µg/ml ascorbic 2-phosphate, 100
µg/ml sodium pyruvate, 40 µg/ml proline and ITS-plus
(consisting of 6.25 µg/ml bovine insulin, 6.25 µg/ml
transferrin, 6.25 µg/ml selenous acid, 5.33 µg/ml linoleic
acid and 1.25 mg/ml bovine serum albumin; Sigma,
Taufkirchen, Germany). Medium was changed twice per
week. To monitor chondrogenic differentiation RT-PCR
analysis for aggrecan and collagen types I, II, IX and X was
performed. Additionally, sections were cut through the
center of the pellets and stained with alcian blue and were
subjected to immunohistochemical analyses for collagen
type II, chondroitin sulphate 4 and 6 as described by Nöth
et al. [36].
RNA Isolation and RT-PCR
RNA isolates were obtained from cells within the differen-
tiation pathways as well as control isolates. Controls for
monolayer differentiation (i.e. into adipocytes and oste-
oblasts) represent confluent resting MSC at day 0 prior to
the initiation of cell differentiation. Control RNA isolates
Table 1: Primers used for RT-PCR
gene product primer sequence # in database entry
CYR61/CCN1 sense 5'ACCAGTCAGGTTTACTTACG 3' 962 – 981 NM_001554
antisense 5'TGCCTCTCACAGACACTCAT 3' 1679 – 1698 NM_001554
CTGF/CCN2 sense 5'AACACCATAGGTAGAATGTAAAGC 3' 1921 – 1944 NM_001901
antisense 5'CTGATCAGCTATATAGAGTCACTC 3' 2130 – 2153 NM_001901
WISP2/CCN5 sense 5'CACGCATAGGCTTGTATTCAGGAAC 3' 1052 – 1075 NM_003881
antisense 5'CACGCTGCCTGGTCTGTCTGGATC 3' 1379 – 1403 NM_003881
WIS32/CCN6 sense 5'CTGTGTTACATTCAGCCTTGCGAC 3' 846 – 869 NM_003880
antisense 5'CTTGGTTTTACAGAATCTTGAGCTC 3' 1158 – 1182 NM_003880
actin sense 5'CGGGAAATCGTGCGTGACAT 3' 689 – 708 NM_001101
antisense 5'GAACTTTGGGGGATGCTCGC 3' 1381 – 1400 NM_001101Cell Communication and Signaling 2005, 3:5 http://www.biosignaling.com/content/3/1/5
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for the chondrogenic differentiation pathway were done
from pellets prior to the initiation of chondrogenic differ-
entiation at day 0. RNA isolation was performed using
purification columns (Qiagen, Hilden, Germany) accord-
ing to the manufacturer. Cells were rinsed with PBS, lysis
buffer was added, RNA was column purified and the yield
was determined by spectrophotometry. cDNA synthesis
was done in a 20 µl reaction using Super Script II Reverse
Transcriptase (Invitrogen, Karlsruhe, Germany) with
identical amounts of RNA isolated from individual
differentiation pathways of MSC (1 µg). PCR was per-
formed using a PTC-200 thermal cycler (MJ Research) in a
volume of 30 µl containing 1 µl cDNA with primers
(Table 1) for CCN family members as well as the house-
keeping gene actin. Primers used for cell markers are
presented in Table 2. The PCR buffer consisted of 10 mM
Tris (pH 8.4), 50 mM KCl, 1.5 mM MgCl2, 0.25 mM
dNTP's, 5 pmol forward and reverse primer, and 0.5 units
of Taq polymerase. Cycling was 4 min at 94°C, 25 – 40
cycles (25 cycles: actin and E1α , 30 – 37 cycles for CCN
members) of 94°C for 30 s, 58 – 64°C for 1 min (depend-
ing on the primers) and 72°C for 1 min, with a final 72°C
step of 5 min. Sequence analysis was performed by dye
terminator sequencing of the PCR products to verify spe-
cificity using an ABI 310 Sequencer. 10 µl of PCR products
were separated on a 2% agarose gel containing ethidium
bromide. In cases of differential PCR product intensities
densitometry was performed using an LTF densitometer
and the bioprofile software (LTF, Wasserburg, Germany)
Table 2: Primers used for RT-PCR of markers for MSC-derived differentiation pathways
Alkaline phosphatase
sense 5'TGGAGCTTCAGAAGCTCAACACCA 3' 368 – 391 NM_000478
antisense 5'ATCTCGTTGTCTGAGTACCAGTCC 3' 798 – 821 NM_000478
Osteocalcin
sense 5'ATGAGAGCCCTCACACTCCTC 3' 19 – 39 NM_199173
antisense 5' GCCGTAGAAGCGCCGATAGGC 3' 292 – 312 NM_199173
Lipoprotein lipase
sense 5'GAGATTTCTCTGTATGGCACC 3' 1261 – 1281 NM_000237
antisense 5'CTGCAAATGAGACACTTTCTC 3' 1516 – 1536 NM_000237
PPARγ 2
sense 5'GCTGTTATGGGTGAAACTCTG 3' 128 – 148 NM_015869
antisense 5'ATAAGGTGGAGATGCAGGCTC 3' 458 – 478 NM_015869
Collagen type II
sense 5'GAACATCACCTACCACTGCAAG 3' 4318 – 4339 NM_001844
antisense 5'GCAGAGTCCTAGAGTGACTGAG 3' 4684 – 4705 NM_001844
Collagen type X
sense 5'CCCTTTTTGCTGCTAGTATCC 3' 112 – 132 NM_000493
antisense 5'CTGTTGTCCAGGTTTTCCTGGCAC 3' 556 – 579 NM_000493
Collagen type XI
sense 5'ACTTCTGACTGCCTCTGCTC 3' 5418 – 5437 NM_001854
antisense 5'GCTTTTGCCATGTGATTCTGCC 3' 5891 – 5912 NM_001854
Aggrecan
sense 5'GCCTTGAGCAGTTCACCTTC 3' 1814 – 1833 NM_001135
antisense 5'CTCTTCTACGGGGACAGCAG 3' 2186 – 2205 NM_001135
Chondroadherin
sense 5'ACCTGGACCACAACAAGGTC 3' 535 – 554 NM_001267
antisense 5'CACCTTCTCCAGGTTGGTGT 3' 907 – 923 NM_001267
Fibromodulin
sense 5'CTTACCCCTATGGGGTGGAT 3' 175 – 194 NM_002023
antisense 5'AAGTAGCTATCGGGGACGGT 3' 792 – 811 NM_002023Cell Communication and Signaling 2005, 3:5 http://www.biosignaling.com/content/3/1/5
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Immunohistochemistry
MSC undergoing osteogenic differentiation were sub-
jected to immunohistochemical analysis for CYR61
expression. Cells were rinsed with PBS, covered with a
glass cover slip and analyzed immediately. As the primary
antibody an anti mouse CYR61 polyclonal antiserum
(Munin, Chicago, USA) at a 1:100 dilution in PBS was
used and the slides were incubated at 4°C overnight. The
further steps were carried out at room temperature. Fol-
lowing three 5 min washes with TBS a monoclonal mouse
anti rabbit IgG (DAKO, Hamburg, Germany) antibody at
a 1:50 dilution in a solution consisting of 100 µl human
AB plasma in 700 µl PBS was added and incubated for 30
min. After rinsing with PBS a rabbit anti mouse IgG
antiserum (DAKO, Hamburg, Germany) diluted 1:25 was
added and incubated for 10 min. After rinsing in PBS cells
were incubated with a complex of intestinal alkaline
phosphatase and mouse monoclonal anti alkaline phos-
phatase antiserum (APAAP) (DAKO, Hamburg, Ger-
many) at a 1:50 dilution for 10 min. The final signal
intensity was amplified using 2 additional cycles of incu-
bations with the rabbit anti mouse IgG antiserum and the
APAAP complex. Signals were developed using a conven-
tional freshly prepared fast-red staining solution (40 mg
fast red, 18 mg levamisole and 20 mg naphtol-AS-MX-
phosphate, 1 ml DMF and 40 ml propanediol-buffer
consisting of 50 mM 2-amino-2 methyl 1,3 propanediol
pH = 8.7). Following a 10 min incubation, sections were
washed in ddH2O and prepared for microscopy.
During every analysis a negative control was performed
according to Wong et al. [22]. Sections were incubated
using a rabbit serum instead of the primary antibody (rab-
bit anti CYR61 antiserum) at a similar protein concentra-
tion. Microscopic images were acquired using a digital
camera and IP-Lab-Spectrum analysis software.
Immunohistochemical analyses for markers of chondro-
genic differentiation were performed using the antisera.
Immunoreactivity was detected using a streptavidin-per-
oxidase staining as described [36].
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